<DOC>
	<DOCNO>NCT00553878</DOCNO>
	<brief_summary>Patient intermittent androgen deprivation protocol biochemical recurrence radical local therapy prostate cancer , addition continuous dutasteride treatment , significantly prolong duration treatment interval time androgen independence .</brief_summary>
	<brief_title>Comparing 0.5 mg Dutasteride v Placebo Daily Men Receiving Androgen Ablation Therapy Prostate Cancer</brief_title>
	<detailed_description>The study assess effect therapy repeat oral daily dose dutasteride 05 mg length treatment interval men receive intermittent androgen therapy localize prostate cancer .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Dutasteride</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>Able give inform consent Age_ &gt; 45and &lt; _80 Histological confirm adenocarcinoma prostate Has receive external beam radiation , brachytherapy radical prostatectomy treatment prostate ca Candidate intermittent androgen ablation Minimum 3 PSA value nadir take least 1 month apart Serum testosterone &gt; _250ng/dl , ECOG 0 1 Negative bone scan within 12 month visit 1 Able swallow retain oral medication Previous treatment chemotherapy Hormonal therapy last year Glucocorticoid last 3 month LHRH analogue previous year Ketoconazole Non Steroidal antiandrogens previous year Concurrent previous use Finasteride Dutasteride 5a reductase inhibitor anabolic steroid Over counter herbal prep saw palmetto selenium vitamin E within last year May receive investigational drug last 30 day Evidence distant metastasis Has receive adjuvant neoadjuvant ablation past 12 month Unstable serious coexist medical condition Abnormal liver kidney function Previous malignancy include curative treat basal cell carcinoma skin 5 year bladder cancer past 2 year Known hypersensitivity 5areductase inhibitor drug chemically related dutasteride Known hypersensitivity bicalutamide .</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>